Advancements in Brain-Computer Interfaces: Rodney Gorham's Journey with Synchron

Rodney Gorham, a 65-year-old man with amyotrophic lateral sclerosis (ALS), has reached a significant milestone by living with a brain-computer interface (BCI) implanted for five years. Developed by the startup Synchron, this experimental device enables Gorham to control computers and digital devices solely through his thoughts. As the longest-term user of Synchron's implant, Gorham has played a crucial role in refining the technology, which aims to assist individuals with paralysis. He received the implant in December 2020 during a clinical trial in Australia, contributing to the ongoing evolution of BCI technology.

Wired Magazine

Synchron's BCI, known as the Stentrode, is a small mesh tube that is inserted into a blood vessel near the brain. It collects neural signals from the motor cortex, the area responsible for voluntary movement. The device is surgically placed in the jugular vein and threaded to the brain, where it captures brain activity and transmits this information to an external receiver. Tom Oxley, Synchron’s CEO, noted that Gorham's participation has been instrumental in testing various interaction methods and application integrations, helping to shape the product's development.

Wired Magazine

Synchron is preparing for a pivotal trial necessary for regulatory approval from the U.S. Food and Drug Administration (FDA). The company is currently in discussions with the FDA to establish clinical endpoints that will measure the safety and effectiveness of the Stentrode. This trial is essential for determining the BCI's potential as a viable treatment option for individuals with severe mobility impairments.

Wired Magazine

Assessing the effectiveness of brain-computer interfaces presents unique challenges compared to traditional medical devices. BCIs utilize decoding algorithms to interpret brain activity and translate it into intended actions. For individuals with paralysis, the challenge lies in recognizing the specific neural patterns associated with their intended movements, even when they cannot physically perform those actions. This complexity is a focal point of ongoing research in the field, as developers work to enhance the reliability of these systems.

Wired Magazine

While advancements in BCI technology are promising, there are concerns regarding the ethical implications and long-term effects of such devices. Critics argue that the commercialization of BCIs could lead to disparities in access to technology, particularly for marginalized populations. Additionally, the potential for misuse of neural data raises questions about privacy and consent.

Wired Magazine

• “We've done a lot of trial and error with Rodney trying out different things to figure out what we think the first use case we should build the first product and clinical trial around,” — Tom Oxley, CEO of Synchron

Wired Magazine

• “Determining the effectiveness of a brain-computer interface is a bit trickier than a traditional drug or device that directly treats a disease, and it’s a question that the field is currently grappling with.” — Expert Commentary

Wired Magazine

As Synchron moves forward with its clinical trials, the implications of Gorham's experience and the broader development of brain-computer interfaces will continue to unfold, potentially transforming the landscape of assistive technology for individuals with severe disabilities.

Wired Magazine